Sofia D. Merajver - Publications

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Epidemiology, Public Health, Molecular Biology

185 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Rosselli-Murai LK, Yates JA, Yoshida S, Bourg J, Ho KKY, White M, Prisby J, Tan X, Altemus M, Bao L, Wu ZF, Veatch S, Swanson J, Merajver S, Liu AP. Loss of PTEN promotes formation of signaling-capable clathrin-coated pits. Journal of Cell Science. PMID 29588397 DOI: 10.1242/jcs.208926  0.32
2016 Allen SG, Chen YC, Madden JM, Fournier CL, Altemus MA, Hiziroglu AB, Cheng YH, Wu ZF, Bao L, Yates JA, Yoon E, Merajver SD. Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling. Scientific Reports. 6: 39190. PMID 27991524 DOI: 10.1038/srep39190  0.32
2016 Chen W, Allen SG, Reka AK, Qian W, Han S, Zhao J, Bao L, Keshamouni VG, Merajver SD, Fu J. Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics. Bmc Cancer. 16: 614. PMID 27501846 DOI: 10.1186/s12885-016-2638-x  0.68
2016 Jiagge E, Jibril AS, Chitale D, Bensenhaver JM, Awuah B, Hoenerhoff M, Adjei E, Bekele M, Abebe E, Nathanson SD, Gyan K, Salem B, Oppong J, Aitpillah F, Kyei I, ... ... Merajver SD, et al. Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer. Annals of Surgical Oncology. PMID 27469125 DOI: 10.1245/s10434-016-5420-z  0.68
2016 Allen SG, Soliman AS, Toy K, Omar OS, Youssef T, Karkouri M, Ayad E, Abdel-Aziz A, Hablas A, Tahri A, Oltean HN, Kleer CG, Merajver SD. Chronic Mastitis in Egypt and Morocco: Differentiating between Idiopathic Granulomatous Mastitis and IgG4-Related Disease. The Breast Journal. PMID 27279578 DOI: 10.1111/tbj.12628  0.68
2016 Wynn M, Kidwell KM, Merajver SD. The Impact of Nathan Mantel's "The Detection of Disease Clustering and a Generalized Regression Approach". Cancer Research. 76: 2495-2496. PMID 27197259 DOI: 10.1158/0008-5472.CAN-16-0883  0.68
2016 Kang Q, Henry NL, Paoletti C, Jiang H, Vats P, Chinnaiyan AM, Hayes DF, Merajver SD, Rae JM, Tewari M. Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes. Clinical Biochemistry. PMID 27129799 DOI: 10.1016/j.clinbiochem.2016.03.012  0.68
2016 Wynn ML, Yates JA, Evans CR, Van Wassenhove L, Wu ZF, Bridges S, Bao L, Fournier C, Ashrafzadeh S, Merrins MJ, Satin LS, Schnell S, Burant CF, Merajver SD. RhoC is a Potent Regulator of Glutamine Metabolism and N-acetylaspartate Production in Inflammatory Breast Cancer Cells. The Journal of Biological Chemistry. PMID 27129239 DOI: 10.1074/jbc.M115.703959  0.68
2016 Maslowsky J, Frost S, Hendrick CE, Trujillo Cruz FO, Merajver SD. Effects of postpartum mobile phone-based education on maternal and infant health in Ecuador. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. PMID 27126905 DOI: 10.1016/j.ijgo.2015.12.008  0.68
2016 Jones T, Lockhart JS, Mendelsohn-Victor KE, Duquette D, Northouse LL, Duffy SA, Donley R, Merajver SD, Milliron KJ, Roberts JS, Katapodi MC. Use of Cancer Genetics Services in African-American Young Breast Cancer Survivors. American Journal of Preventive Medicine. PMID 27117712 DOI: 10.1016/j.amepre.2016.03.016  0.68
2016 Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, ... ... Merajver SD, et al. Genetic/familial high-risk assessment: Breast and ovarian, version 2.2015 Featured updates to the NCCN guidelines Jnccn Journal of the National Comprehensive Cancer Network. 14: 153-162.  0.68
2015 Schlichting JA, Soliman AS, Schairer C, Harford JB, Hablas A, Ramadan M, Seifeldin I, Merajver SD. Breast Cancer by Age at Diagnosis in the Gharbiah, Egypt, Population-Based Registry Compared to the United States Surveillance, Epidemiology, and End Results Program, 2004-2008. Biomed Research International. 2015: 381574. PMID 26495294 DOI: 10.1155/2015/381574  0.68
2015 Song Q, Merajver SD, Li JZ. Cancer classification in the genomic era: five contemporary problems. Human Genomics. 9: 27. PMID 26481255 DOI: 10.1186/s40246-015-0049-8  0.68
2015 Bevers TB, Ward JH, Arun BK, Colditz GA, Cowan KH, Daly MB, Garber JE, Gemignani ML, Gradishar WJ, Jordan JA, Korde LA, Kounalakis N, Krontiras H, Kumar S, Kurian A, ... ... Merajver SD, et al. Breast Cancer Risk Reduction, Version 2.2015. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 880-915. PMID 26150582  0.68
2015 Chen YC, Allen SG, Ingram PN, Buckanovich R, Merajver SD, Yoon E. Single-cell Migration Chip for Chemotaxis-based Microfluidic Selection of Heterogeneous Cell Populations. Scientific Reports. 5: 9980. PMID 25984707 DOI: 10.1038/srep09980  0.68
2015 Kaushal N, Durmaz YY, Bao L, Merajver SD, ElSayed MEH. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells Molecular Pharmaceutics. 12: 2406-2417. DOI: 10.1021/acs.molpharmaceut.5b00114  0.68
2015 Pilie PG, Milliron KJ, Merajver SD. DCIS and hereditary susceptibility for breast cancer Ductal Carcinoma in Situ and Microinvasive/Borderline Breast Cancer. 147-154. DOI: 10.1007/978-1-4939-2035-8_15  0.68
2014 Meernik C, Soliman AS, Ngoma T, Kahesa C, Mwaiselage J, Merajver SD. The changing pattern of ano-rectal cancer, squamous cell carcinoma of the eye, and Hodgkin's lymphoma as non-AIDS-defining cancers, by HIV status, in Tanzania over 11 years (2002-2012): a retrospective case-report study. Infectious Agents and Cancer. 9: 42. PMID 25926865 DOI: 10.1186/1750-9378-9-42  0.68
2014 Wynn ML, Consul N, Merajver SD, Schnell S. Inferring the Effects of Honokiol on the Notch Signaling Pathway in SW480 Colon Cancer Cells. Cancer Informatics. 13: 1-12. PMID 25392689 DOI: 10.4137/CIN.S14060  0.68
2014 Obrist M, Osei-Bonsu E, Awuah B, Watanabe-Galloway S, Merajver SD, Schmid K, Soliman AS. Factors related to incomplete treatment of breast cancer in Kumasi, Ghana. Breast (Edinburgh, Scotland). 23: 821-8. PMID 25282667 DOI: 10.1016/j.breast.2014.08.014  0.68
2014 Daly MB, Pilarski R, Axilbund JE, Buys SS, Crawford B, Friedman S, Garber JE, Horton C, Kaklamani V, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Marcom PK, ... Merajver SD, et al. Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. Journal of the National Comprehensive Cancer Network : Jnccn. 12: 1326-38. PMID 25190698  0.68
2014 Scherber S, Soliman AS, Awuah B, Osei-Bonsu E, Adjei E, Abantanga F, Merajver SD. Characterizing breast cancer treatment pathways in Kumasi, Ghana from onset of symptoms to final outcome: outlook towards cancer control. Breast Disease. 34: 139-49. PMID 24934170 DOI: 10.3233/BD-140372  0.68
2014 Hirko KA, Soliman AS, Banerjee M, Ruterbusch J, Harford JB, Merajver SD, Schwartz K. A comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007-2009. The Breast Journal. 20: 185-91. PMID 24372839 DOI: 10.1111/tbj.12234  0.68
2013 Oltean HN, Soliman AS, Omar OS, Youssef TF, Karkouri M, Abdel-Aziz A, Hablas A, Blachley T, Tahri A, Merajver SD. Risk factors for chronic mastitis in morocco and egypt. International Journal of Inflammation. 2013: 184921. PMID 24327928 DOI: 10.1155/2013/184921  0.68
2013 Hirko KA, Soliman AS, Hablas A, Seifeldin IA, Ramadan M, Banerjee M, Harford JB, Chamberlain RM, Merajver SD. Trends in Breast Cancer Incidence Rates by Age and Stage at Diagnosis in Gharbiah, Egypt, over 10 Years (1999-2008). Journal of Cancer Epidemiology. 2013: 916394. PMID 24282410 DOI: 10.1155/2013/916394  0.68
2013 Perng P, Perng W, Ngoma T, Kahesa C, Mwaiselage J, Merajver SD, Soliman AS. Promoters of and barriers to cervical cancer screening in a rural setting in Tanzania. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 123: 221-5. PMID 24095307 DOI: 10.1016/j.ijgo.2013.05.026  0.68
2013 O'Brien KS, Soliman AS, Awuah B, Jiggae E, Osei-Bonsu E, Quayson S, Adjei E, Thaivalappil SS, Abantanga F, Merajver SD. Establishing effective registration systems in resource-limited settings: cancer registration in Kumasi, Ghana. Journal of Registry Management. 40: 70-7. PMID 24002131  0.68
2013 Balkrishnan R, Chang J, Patel I, Yang F, Merajver SD. Global comparative healthcare effectiveness research: evaluating sustainable programmes in low & middle resource settings. The Indian Journal of Medical Research. 137: 494-501. PMID 23640555  0.68
2013 Akinyemiju TF, Soliman AS, Copeland G, Banerjee M, Schwartz K, Merajver SD. Trends in breast cancer stage and mortality in Michigan (1992-2009) by race, socioeconomic status, and area healthcare resources. Plos One. 8: e61879. PMID 23637921 DOI: 10.1371/journal.pone.0061879  0.68
2013 Katapodi MC, Northouse LL, Schafenacker AM, Duquette D, Duffy SA, Ronis DL, Anderson B, Janz NK, McLosky J, Milliron KJ, Merajver SD, Duong LM, Copeland G. Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening. Bmc Cancer. 13: 97. PMID 23448100 DOI: 10.1186/1471-2407-13-97  0.68
2013 Hirko KA, Soliman AS, Banerjee M, Ruterbusch J, Harford JB, Chamberlain RM, Graff JJ, Merajver SD, Schwartz K. Characterizing inflammatory breast cancer among Arab Americans in the California, Detroit and New Jersey Surveillance, Epidemiology and End Results (SEER) registries (1988-2008). Springerplus. 2: 3. PMID 23420611 DOI: 10.1186/2193-1801-2-3  0.68
2013 Chen W, Weng S, Zhang F, Allen S, Li X, Bao L, Lam RH, Macoska JA, Merajver SD, Fu J. Nanoroughened surfaces for efficient capture of circulating tumor cells without using capture antibodies. Acs Nano. 7: 566-75. PMID 23194329 DOI: 10.1021/nn304719q  0.68
2013 Schneider BJ, Lee JS, Hayman JA, Chang AC, Orringer MB, Pickens A, Pan CC, Merajver SD, Urba SG. Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer. Investigational New Drugs. 31: 435-42. PMID 22847786 DOI: 10.1007/s10637-012-9864-0  0.68
2013 Katapodi MC, Northouse LL, Milliron KJ, Liu G, Merajver SD. Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families. Psycho-Oncology. 22: 1336-43. PMID 22826208 DOI: 10.1002/pon.3139  0.68
2012 Wynn ML, Consul N, Merajver SD, Schnell S. Logic-based models in systems biology: a predictive and parameter-free network analysis method. Integrative Biology : Quantitative Biosciences From Nano to Macro. 4: 1323-37. PMID 23072820 DOI: 10.1039/c2ib20193c  0.68
2012 Rosenthal DT, Zhang J, Bao L, Zhu L, Wu Z, Toy K, Kleer CG, Merajver SD. RhoC impacts the metastatic potential and abundance of breast cancer stem cells. Plos One. 7: e40979. PMID 22911725 DOI: 10.1371/journal.pone.0040979  0.68
2012 Sepulchre JA, Merajver SD, Ventura AC. Retroactive signaling in short signaling pathways. Plos One. 7: e40806. PMID 22848403 DOI: 10.1371/journal.pone.0040806  0.68
2012 Schlichting JA, Soliman AS, Schairer C, Schottenfeld D, Merajver SD. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008. Breast Cancer Research and Treatment. 134: 1257-68. PMID 22733221 DOI: 10.1007/s10549-012-2133-2  0.68
2012 O'Brien KS, Soliman AS, Annan K, Lartey RN, Awuah B, Merajver SD. Traditional herbalists and cancer management in Kumasi, Ghana. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 27: 573-9. PMID 22549472 DOI: 10.1007/s13187-012-0370-z  0.68
2012 Rosenthal DT, Merajver SD. Rethinking the war on cancer: multidisciplinary collaborations between biologists and physical scientists. Future Oncology (London, England). 8: 339-41. PMID 22515435 DOI: 10.2217/fon.12.13  0.68
2012 Wynn ML, Merajver SD, Schnell S. Unraveling the complex regulatory relationships between metabolism and signal transduction in cancer. Advances in Experimental Medicine and Biology. 736: 179-89. PMID 22161328 DOI: 10.1007/978-1-4419-7210-1_9  0.68
2012 Uddin N, Fateem E, Hablas A, Seifeldin IA, Brown E, Merajver SD, Soliman AS. Public and professional educational needs for downstaging breast cancer in Egypt. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 27: 149-55. PMID 22057985 DOI: 10.1007/s13187-011-0282-3  0.68
2012 Schlichting JA, Soliman AS, Schairer C, Banerjee M, Rozek LS, Schottenfeld D, Harford JB, Merajver SD. Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 155-65. PMID 22028401 DOI: 10.1158/1055-9965.EPI-11-0833  0.68
2012 Merajver SD, Balkrishnan R. Making the case for integrated assessments of the biological, social, and system determinants of treatment for breast cancer to understand and improve outcomes in patients everywhere. Current Medical Research and Opinion. 28: 415-7. PMID 21995647 DOI: 10.1185/03007995.2011.628650  0.68
2012 Alford SH, Toy K, Merajver SD, Kleer CG. Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression. Breast Cancer Research and Treatment. 132: 429-37. PMID 21614565 DOI: 10.1007/s10549-011-1591-2  0.68
2012 Jiang P, Ventura AC, Sontag ED, Merajver SD, Ninfa AJ, Del Vecchio D. Theoretical biology: Response to comment on "'Load-induced modulation of signal transduction networks': Reconciling ultrasensitivity with bifunctionality?" Science Signaling. 5. DOI: 10.1126/scisignal.2002716  0.68
2012 Chen YC, Allen SG, Wu ZF, Merajver SD, Yoon E. Lymphatic capillary invasion assay by a single cell migration chip Proceedings of the 16th International Conference On Miniaturized Systems For Chemistry and Life Sciences, Microtas 2012. 968-970.  0.68
2011 McInnis MG, Merajver SD. Global mental health: Global strengths and strategies Task-shifting in a shifting health economy. Asian Journal of Psychiatry. 4: 165-71. PMID 23051112 DOI: 10.1016/j.ajp.2011.06.002  0.68
2011 Soliman AS, Kleer CG, Mrad K, Karkouri M, Omar S, Khaled HM, Benider AL, Ayed FB, Eissa SS, Eissa MS, McSpadden EJ, Lo AC, Toy K, Kantor ED, Xiao Q, ... ... Merajver SD, et al. Inflammatory breast cancer in north Africa: comparison of clinical and molecular epidemiologic characteristics of patients from Egypt, Tunisia, and Morocco. Breast Disease. 33: 159-69. PMID 23001584 DOI: 10.3233/BD-2012-000337  0.68
2011 Gilbert SF, Soliman AS, Karkouri M, Quinlan-Davidson M, Strahley A, Eissa M, Dey S, Hablas A, Seifeldin IA, Ramadan M, Benjaafar N, Toy K, Merajver SD. Clinical profile, BRCA2 expression, and the androgen receptor CAG repeat region in Egyptian and Moroccan male breast cancer patients. Breast Disease. 33: 17-26. PMID 22142662 DOI: 10.3233/BD-2010-0323  0.68
2011 Jiang P, Ventura AC, Sontag ED, Merajver SD, Ninfa AJ, Del Vecchio D. Load-induced modulation of signal transduction networks. Science Signaling. 4: ra67. PMID 21990429 DOI: 10.1126/scisignal.2002152  0.68
2011 Wynn ML, Ventura AC, Sepulchre JA, García HJ, Merajver SD. Kinase inhibitors can produce off-target effects and activate linked pathways by retroactivity. Bmc Systems Biology. 5: 156. PMID 21970676 DOI: 10.1186/1752-0509-5-156  0.68
2011 Katapodi MC, Northouse L, Pierce P, Milliron KJ, Liu G, Merajver SD. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not. Oncology Nursing Forum. 38: 572-81. PMID 21875844 DOI: 10.1188/11.ONF.572-581  0.68
2011 Rosenthal DT, Iyer H, Escudero S, Bao L, Wu Z, Ventura AC, Kleer CG, Arruda EM, Garikipati K, Merajver SD. p38γ promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior. Cancer Research. 71: 6338-49. PMID 21862636 DOI: 10.1158/0008-5472.CAN-11-1291  0.68
2011 Spencer B, Banerjee M, Omar S, Khaled H, Anwar N, Zaghloul MS, Eissa S, Kleer CG, Dey S, Merajver SD, Soliman AS. Survival of inflammatory breast cancer patients compared to non-inflammatory breast cancer patients in Egypt. The Breast Journal. 17: 545-7. PMID 21827567 DOI: 10.1111/j.1524-4741.2011.01146.x  0.68
2011 Gilbert SF, Soliman AS, Iniesta M, Eissa M, Hablas A, Seifeldin IA, Strahley A, Banerjee M, Merajver SD. Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients. Breast Cancer Research and Treatment. 129: 575-81. PMID 21505847 DOI: 10.1007/s10549-011-1510-6  0.68
2011 Ossareh HR, Ventura AC, Merajver SD, Del Vecchio D. Long signaling cascades tend to attenuate retroactivity. Biophysical Journal. 100: 1617-26. PMID 21463574 DOI: 10.1016/j.bpj.2011.02.014  0.68
2011 Bosch-Barrera J, Merajver SD, Menéndez JA, Van Poznak C. Direct antitumour activity of zoledronic acid: preclinical and clinical data. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 13: 148-55. PMID 21421459 DOI: 10.1007/s12094-011-0634-9  0.68
2011 Gonzalez ME, DuPrie ML, Krueger H, Merajver SD, Ventura AC, Toy KA, Kleer CG. Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer. Cancer Research. 71: 2360-70. PMID 21406404 DOI: 10.1158/0008-5472.CAN-10-1933  0.68
2011 Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 22: 515-23. PMID 20603440 DOI: 10.1093/annonc/mdq345  0.68
2010 Varedi K SM, Ventura AC, Merajver SD, Lin XN. Multisite phosphorylation provides an effective and flexible mechanism for switch-like protein degradation. Plos One. 5: e14029. PMID 21179196 DOI: 10.1371/journal.pone.0014029  0.68
2010 Burson AM, Soliman AS, Ngoma TA, Mwaiselage J, Ogweyo P, Eissa MS, Dey S, Merajver SD. Clinical and epidemiologic profile of breast cancer in Tanzania. Breast Disease. 31: 33-41. PMID 21109721 DOI: 10.3233/BD-2009-0296  0.68
2010 Rosenthal DT, Iyer H, Escudero S, Ventura AC, Arruda EM, Garikipati K, Merajver SD. From in vitro to in silico and back again: using biological and mathematical synergy to decipher breast cancer cell motility. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2010: 3261-4. PMID 21096609 DOI: 10.1109/IEMBS.2010.5627224  0.68
2010 Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Loftus L, Macdonald DJ, ... ... Merajver SD, et al. Breast cancer risk reduction. Journal of the National Comprehensive Cancer Network : Jnccn. 8: 1112-46. PMID 20971838  0.68
2010 Iniesta MD, Gorin MA, Chien LC, Thomas SM, Milliron KJ, Douglas JA, Merajver SD. Absence of CHEK2*1100delC mutation in families with hereditary breast cancer in North America. Cancer Genetics and Cytogenetics. 202: 136-40. PMID 20875877 DOI: 10.1016/j.cancergencyto.2010.07.124  0.68
2010 Kumar P, Yadav A, Patel SN, Islam M, Pan Q, Merajver SD, Teknos TN. Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis. Molecular Cancer. 9: 206. PMID 20682068 DOI: 10.1186/1476-4598-9-206  0.68
2010 Wu M, Wu ZF, Rosenthal DT, Rhee EM, Merajver SD. Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers. Cancer. 116: 2768-82. PMID 20503409 DOI: 10.1002/cncr.25181  0.68
2010 Ventura AC, Jiang P, Van Wassenhove L, Del Vecchio D, Merajver SD, Ninfa AJ. Signaling properties of a covalent modification cycle are altered by a downstream target. Proceedings of the National Academy of Sciences of the United States of America. 107: 10032-7. PMID 20479260 DOI: 10.1073/pnas.0913815107  0.68
2010 Dey S, Soliman AS, Hablas A, Seifeldein IA, Ismail K, Ramadan M, El-Hamzawy H, Wilson ML, Banerjee M, Boffetta P, Harford J, Merajver SD. Urban-rural differences in breast cancer incidence in Egypt (1999-2006). Breast (Edinburgh, Scotland). 19: 417-23. PMID 20452771 DOI: 10.1016/j.breast.2010.04.005  0.68
2010 Pierce LJ, Phillips KA, Griffith KA, Buys S, Gaffney DK, Moran MS, Haffty BG, Ben-David M, Kaufman B, Garber JE, Merajver SD, Balmaña J, Meirovitz A, Domchek SM. Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy. Breast Cancer Research and Treatment. 121: 389-98. PMID 20411323 DOI: 10.1007/s10549-010-0894-z  0.68
2010 Iniesta MD, Chien J, Wicha M, Merajver SD. One-hit effects and cancer. Cancer Prevention Research (Philadelphia, Pa.). 3: 12-5. PMID 20051368 DOI: 10.1158/1940-6207.CAPR-09-0249  0.68
2010 Dey S, Hablas A, Seifeldin IA, Ismail K, Ramadan M, El-Hamzawy H, Wilson ML, Banerjee M, Boffetta P, Harford J, Merajver SD, Soliman AS. Urban-rural differences of gynaecological malignancies in Egypt (1999-2002). Bjog : An International Journal of Obstetrics and Gynaecology. 117: 348-55. PMID 20015310 DOI: 10.1111/j.1471-0528.2009.02447.x  0.68
2010 Dey S, Soliman AS, Hablas A, Seifeldin IA, Ismail K, Ramadan M, El-Hamzawy H, Wilson ML, Banerjee M, Boffetta P, Harford J, Merajver SD. Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt. Breast Cancer Research and Treatment. 120: 149-60. PMID 19548084 DOI: 10.1007/s10549-009-0427-9  0.68
2010 Ventura AC, Jiang P, Ninfa AJ, Van Wassenhove L, Merajver SD, Del Vecchio D. The impact of retroactivity on the input/output static characteristics of a signaling component Asme 2010 Dynamic Systems and Control Conference, Dscc2010. 1: 313-320. DOI: 10.1115/DSCC2010-4061  0.68
2010 Bosch-Barrera J, Merajver SD. Bisphosphonates in breast cancer: From metastasis to prevention Current Breast Cancer Reports. 2: 222-230. DOI: 10.1007/s12609-010-0025-1  0.68
2010 Rosenthal DT, Brenner JC, Merajver SD. Rho proteins in cancer The Rho Gtpases in Cancer. 29-42. DOI: 10.1007/978-1-4419-1111-7_2  0.68
2009 Chang CW, Wu M, Merajver SD, Mycek MA. Physiological fluorescence lifetime imaging microscopy improves Förster resonance energy transfer detection in living cells. Journal of Biomedical Optics. 14: 060502. PMID 20059233 DOI: 10.1117/1.3257254  0.68
2009 Iniesta MD, Mooney CJ, Merajver SD. Inflammatory breast cancer: what are the treatment options? Expert Opinion On Pharmacotherapy. 10: 2987-97. PMID 19954272 DOI: 10.1517/14656560903401638  0.68
2009 Pan Q, Rosenthal DT, Bao L, Kleer CG, Merajver SD. Antiangiogenic tetrathiomolybdate protects against Her2/neu-induced breast carcinoma by hypoplastic remodeling of the mammary gland. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 7441-6. PMID 19934283 DOI: 10.1158/1078-0432.CCR-09-1361  0.68
2009 Islam M, Lin G, Brenner JC, Pan Q, Merajver SD, Hou Y, Kumar P, Teknos TN. RhoC expression and head and neck cancer metastasis. Molecular Cancer Research : McR. 7: 1771-80. PMID 19861405 DOI: 10.1158/1541-7786.MCR-08-0512  0.68
2009 Khan GN, Gorin MA, Rosenthal D, Pan Q, Bao LW, Wu ZF, Newman RA, Pawlus AD, Yang P, Lansky EP, Merajver SD. Pomegranate fruit extract impairs invasion and motility in human breast cancer. Integrative Cancer Therapies. 8: 242-53. PMID 19815594 DOI: 10.1177/1534735409341405  0.68
2009 Li X, Gonzalez ME, Toy K, Filzen T, Merajver SD, Kleer CG. Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia. The American Journal of Pathology. 175: 1246-54. PMID 19661437 DOI: 10.2353/ajpath.2009.090042  0.68
2009 Soliman AS, Banerjee M, Lo AC, Ismail K, Hablas A, Seifeldin IA, Ramadan M, Omar HG, Fokuda A, Harford JB, Merajver SD. High proportion of inflammatory breast cancer in the Population-based Cancer Registry of Gharbiah, Egypt. The Breast Journal. 15: 432-4. PMID 19601951 DOI: 10.1111/j.1524-4741.2009.00755.x  0.68
2009 Bao L, Gorin MA, Zhang M, Ventura AC, Pomerantz WC, Merajver SD, Teknos TN, Mapp AK, Pan Q. Preclinical development of a bifunctional cancer cell homing, PKCepsilon inhibitory peptide for the treatment of head and neck cancer. Cancer Research. 69: 5829-34. PMID 19567682 DOI: 10.1158/0008-5472.CAN-08-3465  0.68
2009 Lo AC, Georgopoulos A, Kleer CG, Banerjee M, Omar S, Khaled H, Eissa S, Hablas A, Omar HG, Douglas JA, Merajver SD, Soliman AS. Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients. Breast (Edinburgh, Scotland). 18: 55-9. PMID 19157876 DOI: 10.1016/j.breast.2008.11.002  0.68
2009 Dey S, Soliman AS, Merajver SD. Xenoestrogens may be the cause of high and increasing rates of hormone receptor positive breast cancer in the world. Medical Hypotheses. 72: 652-6. PMID 19155145 DOI: 10.1016/j.mehy.2008.10.025  0.68
2009 Ventura AC, Jackson TL, Merajver SD. On the role of cell signaling models in cancer research. Cancer Research. 69: 400-2. PMID 19147549 DOI: 10.1158/0008-5472.CAN-08-4422  0.68
2009 Gonzalez ME, Li X, Toy K, DuPrie M, Ventura AC, Banerjee M, Ljungman M, Merajver SD, Kleer CG. Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1 Oncogene. 28: 843-853. PMID 19079346 DOI: 10.1038/onc.2008.433  0.68
2009 Gartner EM, Griffith KA, Pan Q, Brewer GJ, Henja GF, Merajver SD, Zalupski MM. A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer. Investigational New Drugs. 27: 159-65. PMID 18712502 DOI: 10.1007/s10637-008-9165-9  0.68
2009 Hensley Alford S, Schwartz K, Soliman A, Johnson CC, Gruber SB, Merajver SD. Breast cancer characteristics at diagnosis and survival among Arab-American women compared to European- and African-American women. Breast Cancer Research and Treatment. 114: 339-46. PMID 18415013 DOI: 10.1007/s10549-008-9999-z  0.68
2009 Wasielewski M, Hanifi-Moghaddam P, Hollestelle A, Merajver SD, van den Ouweland A, Klijn JG, Ethier SP, Schutte M. Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines. Breast Cancer Research and Treatment. 113: 285-91. PMID 18297428 DOI: 10.1007/s10549-008-9942-3  0.68
2009 Chang CW, Wu M, Merajver SD, Mycek MA. Improving FRET detection in living cells Progress in Biomedical Optics and Imaging - Proceedings of Spie. 7370. DOI: 10.1117/12.831718  0.68
2008 Houchens NW, Merajver SD. Molecular determinants of the inflammatory breast cancer phenotype. Oncology (Williston Park, N.Y.). 22: 1556-61; discussion . PMID 19198217  0.68
2008 Iniesta MD, Merajver SD. CHEK2 screening: do not think so globally yet. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3092; author reply 3. PMID 18565899 DOI: 10.1200/JCO.2008.16.9151  0.68
2008 Ho TT, Merajver SD, Lapière CM, Nusgens BV, Deroanne CF. RhoA-GDP regulates RhoB protein stability. Potential involvement of RhoGDIalpha. The Journal of Biological Chemistry. 283: 21588-98. PMID 18524772 DOI: 10.1074/jbc.M710033200  0.68
2008 Ventura AC, Sepulchre JA, Merajver SD. A hidden feedback in signaling cascades is revealed. Plos Computational Biology. 4: e1000041. PMID 18369431 DOI: 10.1371/journal.pcbi.1000041  0.68
2008 Huang W, Zhang Y, Varambally S, Chinnaiyan AM, Banerjee M, Merajver SD, Kleer CG. Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1. The American Journal of Pathology. 172: 893-904. PMID 18321996 DOI: 10.2353/ajpath.2008.070899  0.68
2008 Liu S, Ginestier C, Charafe-Jauffret E, Foco H, Kleer CG, Merajver SD, Dontu G, Wicha MS. BRCA1 regulates human mammary stem/progenitor cell fate. Proceedings of the National Academy of Sciences of the United States of America. 105: 1680-5. PMID 18230721 DOI: 10.1073/pnas.0711613105  0.68
2008 Lo AC, Kleer CG, Banerjee M, Omar S, Khaled H, Eissa S, Hablas A, Douglas JA, Alford SH, Merajver SD, Soliman AS. Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients. Breast Cancer Research and Treatment. 112: 141-7. PMID 18058225 DOI: 10.1007/s10549-007-9833-z  0.68
2008 Ventura AC, Merajver SD. Genetic determinants of aggressive breast cancer. Annual Review of Medicine. 59: 199-212. PMID 17914925 DOI: 10.1146/annurev.med.59.060106.184830  0.68
2007 Zhong W, Wu M, Chang CW, Merrick KA, Merajver SD, Mycek MA. Picosecond-resolution fluorescence lifetime imaging microscopy: a useful tool for sensing molecular interactions in vivo via FRET. Optics Express. 15: 18220-35. PMID 19551120 DOI: 10.1364/OE.15.018220  0.68
2007 Khan GN, Merajver SD. Modulation of angiogenesis for cancer prevention: strategies based on antioxidants and copper deficiency. Current Pharmaceutical Design. 13: 3584-90. PMID 18220795 DOI: 10.2174/138161207782794202  0.68
2007 Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Lawton T, Loftus L, ... ... Merajver SD, et al. Breast cancer risk reduction. Journal of the National Comprehensive Cancer Network : Jnccn. 5: 676-701. PMID 17927926  0.68
2007 Evelyn CR, Wade SM, Wang Q, Wu M, Iñiguez-Lluhí JA, Merajver SD, Neubig RR. CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Molecular Cancer Therapeutics. 6: 2249-60. PMID 17699722 DOI: 10.1158/1535-7163.MCT-06-0782  0.68
2007 Wu M, Wu ZF, Merajver SD. Rho proteins and cell-matrix interactions in cancer. Cells, Tissues, Organs. 185: 100-3. PMID 17587814 DOI: 10.1159/000101309  0.68
2007 Kleer CG, Zhang Y, Merajver SD. CCN6 (WISP3) as a new regulator of the epithelial phenotype in breast cancer. Cells, Tissues, Organs. 185: 95-9. PMID 17587813 DOI: 10.1159/000101308  0.68
2007 Wang C, Gonzalez R, Janz NK, Milliron KJ, Merajver SD. The role of cognitive appraisal and worry in BRCA1/2 testing decisions among a clinic population Psychology and Health. 22: 719-736. DOI: 10.1080/14768320600976216  0.68
2007 Das S, Merajver SD. Testing biomarkers: Designing trials as if we believed in them! American Journal of Hematology/ Oncology. 6: 602-603.  0.68
2007 Merajver SD. Further perspectives on inflammatory breast cancer Oncology. 21: 686-687.  0.68
2006 Shah NM, Soliman AS, Benerjee M, Merajver SD, Ismail K, Seifeldin I, Hablas A, Zarzour A, Abdel-Aziz A, Ben Ayed F, Chamberlain RM. Knowledge gained after a brief CME module on breast cancer diagnosis. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 21: 169-74. PMID 17371184 DOI: 10.1207/s15430154jce2103_17  0.68
2006 Pan Q, Bao LW, Teknos TN, Merajver SD. Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma. Cancer Research. 66: 9379-84. PMID 17018591 DOI: 10.1158/0008-5472.CAN-06-2646  0.68
2006 Kleer CG, Teknos TN, Islam M, Marcus B, Lee JS, Pan Q, Merajver SD. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 4485-90. PMID 16899593 DOI: 10.1158/1078-0432.CCR-06-0376  0.68
2006 Pierce LJ, Levin AM, Rebbeck TR, Ben-David MA, Friedman E, Solin LJ, Harris EE, Gaffney DK, Haffty BG, Dawson LA, Narod SA, Olivotto IA, Eisen A, Whelan TJ, Olopade OI, ... ... Merajver SD, et al. Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2437-43. PMID 16636335 DOI: 10.1200/JCO.2005.02.7888  0.68
2006 Ding L, Erdmann C, Chinnaiyan AM, Merajver SD, Kleer CG. Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues. Cancer Research. 66: 4095-9. PMID 16618729 DOI: 10.1158/0008-5472.CAN-05-4300  0.68
2006 Khan MK, Mamou F, Schipper MJ, May KS, Kwitny A, Warnat A, Bolton B, Nair BM, Kariapper MS, Miller M, Brewer G, Normolle D, Merajver SD, Teknos TN. Combination tetrathiomolybdate and radiation therapy in a mouse model of head and neck squamous cell carcinoma. Archives of Otolaryngology--Head & Neck Surgery. 132: 333-8. PMID 16549755 DOI: 10.1001/archotol.132.3.333  0.68
2006 Elstrodt F, Hollestelle A, Nagel JH, Gorin M, Wasielewski M, van den Ouweland A, Merajver SD, Ethier SP, Schutte M. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Research. 66: 41-5. PMID 16397213 DOI: 10.1158/0008-5472.CAN-05-2853  0.68
2006 Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Research and Treatment. 95: 219-28. PMID 16244790 DOI: 10.1007/s10549-005-9002-1  0.68
2005 Merajver SD, Usmani SZ. Multifaceted role of Rho proteins in angiogenesis. Journal of Mammary Gland Biology and Neoplasia. 10: 291-8. PMID 16900393 DOI: 10.1007/s10911-006-9002-8  0.68
2005 Wu M, Merajver SD. Molecular biology of inflammatory breast cancer: applications to diagnosis, prognosis, and therapy. Breast Disease. 22: 25-34. PMID 16735784  0.68
2005 Zhang Y, Pan Q, Zhong H, Merajver SD, Kleer CG. Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells. Breast Cancer Research : Bcr. 7: R1080-9. PMID 16457688 DOI: 10.1186/bcr1351  0.68
2005 Zeidler M, Varambally S, Cao Q, Chinnaiyan AM, Ferguson DO, Merajver SD, Kleer CG. The polycomb group protein EZH2 impairs DNA repair in breast epithelial cells Neoplasia. 7: 1011-1019. PMID 16331887 DOI: 10.1593/neo.05472  0.68
2005 Goodman VL, Brewer GJ, Merajver SD. Control of copper status for cancer therapy. Current Cancer Drug Targets. 5: 543-9. PMID 16305350 DOI: 10.2174/156800905774574066  0.68
2005 Kleer CG, Griffith KA, Sabel MS, Gallagher G, van Golen KL, Wu ZF, Merajver SD. RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast. Breast Cancer Research and Treatment. 93: 101-10. PMID 16187229 DOI: 10.1007/s10549-005-4170-6  0.68
2005 Pan Q, Bao LW, Kleer CG, Sabel MS, Griffith KA, Teknos TN, Merajver SD. Protein kinase Cε is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy Cancer Research. 65: 8366-8371. PMID 16166314 DOI: 10.1158/0008-5472.CAN-05-0553  0.68
2005 Lin M, DiVito MM, Merajver SD, Boyanapalli M, van Golen KL. Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1. Molecular Cancer. 4: 21. PMID 15969750 DOI: 10.1186/1476-4598-4-21  0.68
2005 Teknos TN, Islam M, Arenberg DA, Pan Q, Carskadon SL, Abarbanell AM, Marcus B, Paul S, Vandenberg CD, Carron M, Nor JE, Merajver SD. The effect of tetrathiomolybdate on cytokine expression, angiogenesis, and tumor growth in squamous cell carcinoma of the head and neck. Archives of Otolaryngology--Head & Neck Surgery. 131: 204-11. PMID 15781759 DOI: 10.1001/archotol.131.3.204  0.68
2005 Wang C, Gonzalez R, Milliron KJ, Strecher VJ, Merajver SD. Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process. American Journal of Medical Genetics. Part A. 134: 66-73. PMID 15690408 DOI: 10.1002/ajmg.a.30577  0.68
2005 Zhong W, Sud D, Wu M, Merrick KA, Merajver SD, Beer DG, Mycek MA. Sensing cellular function and molecular activity in vivo using fluorescence lifetime imaging microscopy (FLIM) Progress in Biomedical Optics and Imaging - Proceedings of Spie. 5864: 1-9.  0.68
2004 Marcus B, Arenberg D, Lee J, Kleer C, Chepeha DB, Schmalbach CE, Islam M, Paul S, Pan Q, Hanash S, Kuick R, Merajver SD, Teknos TN. Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma: The impact of tumor-associated macrophages Cancer. 101: 2779-2787. PMID 15546137 DOI: 10.1002/cncr.20701  0.68
2004 Goodman VL, Brewer GJ, Merajver SD. Copper deficiency as an anti-cancer strategy. Endocrine-Related Cancer. 11: 255-63. PMID 15163301 DOI: 10.1677/erc.0.0110255  0.68
2004 Kleer CG, Zhang Y, Pan Q, Merajver SD. WISP3 (CCN6) Is a Secreted Tumor-Suppressor Protein that Modulates IGF Signaling in Inflammatory Breast Cancer Neoplasia. 6: 179-185. PMID 15140407 DOI: 10.1593/neo.03316  0.68
2004 Wu M, Wu ZF, Kumar-Sinha C, Chinnaiyan A, Merajver SD. RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells Breast Cancer Research and Treatment. 84: 3-12. PMID 14999149 DOI: 10.1023/B:BREA.0000018426.76893.21  0.68
2004 Wang C, Gonzalez R, Merajver SD. Assessment of genetic testing and related counseling services: Current research and future directions Social Science and Medicine. 58: 1427-1442. PMID 14759687 DOI: 10.1016/S0277-9536(03)00337-X  0.68
2004 Kleer CG, Zhang Y, Pan Q, Gallagher G, Wu M, Wu ZF, Merajver SD. WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer. Breast Cancer Research : Bcr. 6: R110-5. PMID 14696649  0.68
2004 Kent MS, Madewell BR, Dank G, Dick R, Merajver SD, Brewer GJ. An Anticopper Antiangiogenic Approach for Advanced Cancer in Spontaneously Occurring Tumors Using Tetrathiomolybdate: A Pilot Study in a Canine Animal Model Journal of Trace Elements in Experimental Medicine. 17: 9-20. DOI: 10.1002/jtra.10033  0.68
2003 Merajver SD, Milliron K. Breast cancer risk assessment: A guide for clinicians using the NCCN breast cancer risk reduction guidelines Jnccn Journal of the National Comprehensive Cancer Network. 1: 297-301. PMID 19768887  0.68
2003 Collisson EA, Kleer C, Wu M, De Abhijit, Gambhir SS, Merajver SD, Kolodney MS. Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells Molecular Cancer Therapeutics. 2: 941-948. PMID 14578459  0.68
2003 Pan Q, Bao LW, Merajver SD. Tetrathiomolybdate inhibits angiogenesis and metastasis through suppression of the NFκB signaling cascade Molecular Cancer Research. 1: 701-706. PMID 12939395  0.68
2003 Pan Q, Bao LW, Kleer CG, Brewer GJ, Merajver SD. Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma. Molecular Cancer Therapeutics. 2: 617-22. PMID 12883034  0.68
2003 Cox C, Merajver SD, Yoo S, Dick RD, Brewer GJ, Lee JS, Teknos TN. Inhibition of the growth of squamous cell carcinoma by tetrathiomolybdate-induced copper suppression in a murine model. Archives of Otolaryngology--Head & Neck Surgery. 129: 781-5. PMID 12874082 DOI: 10.1001/archotol.129.7.781  0.68
2003 Redman BG, Esper P, Pan Q, Dunn RL, Hussain HK, Chenevert T, Brewer GJ, Merajver SD. Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 1666-72. PMID 12738719  0.68
2002 Brewer GJ, Merajver SD. Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review. Integrative Cancer Therapies. 1: 327-37. PMID 14664727 DOI: 10.1177/1534735402238185  0.68
2002 van Golen KL, Bao L, DiVito MM, Wu Z, Prendergast GC, Merajver SD. Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor. Molecular Cancer Therapeutics. 1: 575-83. PMID 12479217  0.68
2002 Pan Q, Kleer CG, van Golen KL, Irani J, Bottema KM, Bias C, De Carvalho M, Mesri EA, Robins DM, Dick RD, Brewer GJ, Merajver SD. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Research. 62: 4854-9. PMID 12208730  0.68
2002 van Golen KL, Bao L, Brewer GJ, Pienta KJ, Kamradt JM, Livant DL, Merajver SD. Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma. Neoplasia (New York, N.Y.). 4: 373-9. PMID 12192595 DOI: 10.1038/sj.neo.7900258  0.68
2002 Kleer CG, Tseng MD, Gutsch DE, Rochford RA, Wu Z, Joynt LK, Helvie MA, Chang T, Van Golen KL, Merajver SD. Detection of Epstein-Barr virus in rapidly growing fibroadenomas of the breast in immunosuppressed hosts. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 15: 759-64. PMID 12118114 DOI: 10.1038/modpathol.3880602  0.68
2002 van Golen KL, Bao LW, Pan Q, Miller FR, Wu ZF, Merajver SD. Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer. Clinical & Experimental Metastasis. 19: 301-11. PMID 12090470 DOI: 10.1023/A:1015518114931  0.68
2002 Kleer CG, Zhang Y, Pan Q, van Golen KL, Wu ZF, Livant D, Merajver SD. WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Oncogene. 21: 3172-80. PMID 12082632 DOI: 10.1038/sj.onc.1205462  0.68
2002 Munshi HG, Merajver SD, Valdez R, Baker LH, Cooney KA. Metastatic dedifferentiated chordoma with elevated beta-hCG: a case report. American Journal of Clinical Oncology. 25: 274-6. PMID 12040287 DOI: 10.1097/00000421-200206000-00014  0.68
2002 Khan MK, Miller MW, Taylor J, Gill NK, Dick RD, Van Golen K, Brewer GJ, Merajver SD. Radiotherapy and antiangiogenic TM in lung cancer. Neoplasia (New York, N.Y.). 4: 164-70. PMID 11896571 DOI: 10.1038/sj/neo/7900218  0.68
2002 Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. The American Journal of Pathology. 160: 579-84. PMID 11839578 DOI: 10.1016/S0002-9440(10)64877-8  0.68
2002 Peterson EA, Milliron KJ, Lewis KE, Goold SD, Merajver SD. Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 11: 79-87. PMID 11815404  0.68
2001 Trask PC, Paterson AG, Wang C, Hayasaka S, Milliron KJ, Blumberg LR, Gonzalez R, Murray S, Merajver SD. Cancer-specific worry interference in women attending a breast and ovarian cancer risk evaluation program: Impact on emotional distress and health functioning Psycho-Oncology. 10: 349-360. PMID 11536413 DOI: 10.1002/pon.510  0.68
2001 Cox C, Teknos TN, Barrios M, Brewer GJ, Dick RD, Merajver SD. The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma. The Laryngoscope. 111: 696-701. PMID 11359142 DOI: 10.1097/00005537-200104000-00024  0.68
2001 Kleer CG, Van Golen KL, Braun T, Merajver SD. Persistent E-cadherin expression in inflammatory breast cancer Modern Pathology. 14: 458-464. PMID 11353057 DOI: 10.1038/modpathol.3880334  0.68
2001 Merajver SD, Milliron KJ. The Srivastava/McKinnon/Wood article reviewed Oncology. 15.  0.68
2000 Kleer CG, van Golen KL, Merajver SD. Molecular biology of breast cancer metastasis. Inflammatory breast cancer: Clinical syndrome and molecular determinants Breast Cancer Research. 2: 423-429. PMID 11250736 DOI: 10.1186/bcr89  0.68
2000 Van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD. RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells Neoplasia. 2: 418-425. PMID 11191108  0.68
2000 Van Golen KL, Wu ZF, Xiao Tan Qiao, Li Wei Bao, Merajver SD. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype Cancer Research. 60: 5832-5838. PMID 11059780  0.68
2000 Brewer GJ, Dick RD, Grover DK, LeClaire V, Tseng M, Wicha M, Pienta K, Redman BG, Jahan T, Sondak VK, Strawderman M, LeCarpentier G, Merajver SD. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 6: 1-10. PMID 10656425  0.68
1999 Van Golen KL, Davies S, Wu ZF, Wang Y, Bucana CD, Root H, Chandrasekharappa S, Strawderman M, Ethier SP, Merajver SD. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype Clinical Cancer Research. 5: 2511-2519. PMID 10499627  0.68
1999 Van Golen K, Milliron K, Davies S, Merajver SD. BRCA-associated cancer risk: Molecular biology and clinical practice Journal of Laboratory and Clinical Medicine. 134: 11-18. PMID 10402055 DOI: 10.1016/S0022-2143(99)90049-5  0.68
1997 Merajver SD, Weber BL, Cody R, Zhang D, Strawderman M, Calzone KA, LeClaire V, Levin A, Irani J, Halvie M, August D, Wicha M, Lichter A, Pierce LJ. Breast conservation and prolonged chemotherapy for locally advanced breast cancer: The University of Michigan experience Journal of Clinical Oncology. 15: 2873-2881. PMID 9256131  0.68
1997 Helvie MA, Roubidoux MA, Weber BL, Merajver SD. Mammography of breast carcinoma in women who have mutations of the breast cancer gene BRCA1: Initial experience American Journal of Roentgenology. 168: 1599-1602. PMID 9168735  0.68
1996 Abel KJ, Brody LC, Valdes JM, Erdos MR, McKinley DR, Castilla LH, Merajver SD, Couch FJ, Friedman LS, Ostermeyer EA, Lynch ED, King MC, Welcsh PL, Osborne-Lawrence S, Spillman M, et al. Characterization of EZH1, a human homolog of Drosophila enhancer of zeste near BRCA1 Genomics. 37: 161-171. PMID 8921387 DOI: 10.1006/geno.1996.0537  0.68
1996 Merajver SD, Petty EM. Risk assessment and presymptomatic molecular diagnosis in hereditary breast cancer Clinics in Laboratory Medicine. 16: 139-167. PMID 8867588  0.68
1996 Simon JS, Deshmukh G, Couch FJ, Merajver SD, Weber BL, Van Vooren P, Tissil F, Szpirer J, Szpirer C, Alper SL, Jacob HJ, Brosius FC. Chromosomal mapping of the rat Slc4a family of anion exchanger genes, Ae1, Ae2, and Ae3 Mammalian Genome. 7: 380-382. PMID 8661729  0.68
1996 Cooney KA, Wetzel JC, Merajver SD, Macoska JA, Singleton TP, Wojno KJ. Distinct regions of allelic loss on 13q in prostate cancer. Cancer Research. 56: 1142-5. PMID 8640774  0.68
1996 Caduff RF, Johnston CM, Svoboda-Newman SM, Poy EL, Merajver SD, Frank TS. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. The American Journal of Pathology. 148: 1671-8. PMID 8623934  0.68
1996 Helvie MA, Joynt LK, Cody RL, Pierce LJ, Adler DD, Merajver SD. Locally advanced breast carcinoma: Accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy Radiology. 198: 327-332. PMID 8596826  0.68
1995 Merajver SD, Frank TS, Xu J, Pham TM, Calzone KA, Bennett-Baker P, Chamberlain J, Boyd J, Garber JE, Collins FS. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 1: 539-44. PMID 9816013  0.68
1995 Couch FJ, Garber J, Kiousis S, Calzone K, Hauser ER, Merajver SD, Frank TS, Boehnke M, Chamberlain JS, Collins FS. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations. Journal of the National Cancer Institute. Monographs. 9-14. PMID 8573462  0.68
1995 Hoskins KF, Stopfer JE, Calzone KA, Weber BL, Merajver SD, Rebbeck TR, Garber JE. Assessment and Counseling for Women With a Family History of Breast Cancer: A Guide for Clinicians Jama: the Journal of the American Medical Association. 273: 577-585. PMID 7837392 DOI: 10.1001/jama.1995.03520310075033  0.68
1995 Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C, Frank TS. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature Genetics. 9: 439-43. PMID 7795652 DOI: 10.1038/ng0495-439  0.68
1994 Weber BL, Abel KJ, Brody LC, Flejter WL, Chandrasekharappa SC, Couch FJ, Merajver SD, Collins FS. Familial breast cancer: Approaching the isolation of a susceptibility gene Cancer. 74: 1013-1020. PMID 8039134 DOI: 10.1002/1097-0142(19940801)74:3+<1013::AID-CNCR2820741507>3.0.CO;2-#  0.68
1994 Weber BL, Abel KJ, Couch FJ, Merajver SD, Chandrasekharappa SC, Castilla L, McKinley D, Ho PP, Calzone K, Frank TS. Progress toward isolation of a breast cancer susceptibility gene, BRCA1. Cold Spring Harbor Symposia On Quantitative Biology. 59: 531-6. PMID 7587109  0.68
1987 Kikuchi GE, Baker SA, Merajver SD, Coligan JE, Levine M, Glorioso JC, Nairn R. Purification and structural characterization of herpes simplex virus glycoprotein C. Biochemistry. 26: 424-31. PMID 3030409  0.68
1986 Wunder SL, Merajver SD. Ultrahigh‐molecular‐weight polyethylene: Raman spectroscopic study of melt anisotropy Journal of Polymer Science Part B: Polymer Physics. 24: 99-110. DOI: 10.1002/polb.1986.180240111  0.68
1986 Wunder SL, Merajver SD. Ultrahigh-molecular-weight polyethylene: Raman spectroscopic study of melt anisotropy 0.68
1982 Merajver SD, Lapidus C, Wunder SL. Intermolecular interactions and Fermi resonance in methylene groups The Journal of Chemical Physics. 76: 3344-3345.  0.68
1981 Merajver SD, Sheridan JP, Siguel EN. Theory of the conformational order of single component sphingomyelin bilayers Journal of Theoretical Biology. 93: 737-755. PMID 7341875 DOI: 10.1016/0022-5193(81)90337-4  0.68
1981 Ziff RM, Merajver SD, Stell G. Approach to equilibrium of a Boltzmann-equation solution Physical Review Letters. 47: 1493-1496. DOI: 10.1103/PhysRevLett.47.1493  0.68
1981 Merajver SD, Yorke ED, De Rocco AG. Random-walk model of the phase transition of hydrocarbon chains on a lattice Physical Review A. 23: 897-907. DOI: 10.1103/PhysRevA.23.897  0.68
1981 Merajver SD. Characterization of hexadecanoic acid perdeuterated from carbon eight to carbon sixteen: a novel conformational probe for amphipathic systems Chemistry and Physics of Lipids. 29: 379-384. DOI: 10.1016/0009-3084(81)90072-4  0.68
1981 Wunder SL, Merajver SD. Raman spectroscopic study of the conformational order in hexadecane solutions The Journal of Chemical Physics. 74: 5341-5346.  0.68
Show low-probability matches.